Related Experiment Videos

[Guideline for chemotherapy of malignant lung cancer]

Nobuyuki Yamamoto, Masahiro Fukuoka

Gan to Kagaku Ryoho. Cancer & Chemotherapy

|July 12, 2002

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Public assistance and survival equality in patients with EGFR mutation-positive lung cancer.

Japanese journal of clinical oncology·2024

Feasibility Study of Nivolumab in Combination with Carboplatin Plus Paclitaxel and Concurrent Thoracic Radiation in Patients with Untreated Unresectable Locally Advanced Non-Small Cell Lung Cancer.

Cancers·2024

Prognostic impact of concomitant pH-regulating drugs in patients with non-small cell lung cancer receiving epidermal growth factor receptor tyrosine kinase inhibitors: the Tokushukai REAl-world Data project 01-S1.

Cancer chemotherapy and pharmacology·2024

Stepwise prolongation of overall survival from first to third generation EGFR-TKIs for EGFR mutation-positive non-small-cell lung cancer: the Tokushukai REAl-world Data project (TREAD 01).

Japanese journal of clinical oncology·2023

Biomarker analysis of the phase II JO25567 study comparing erlotinib with or without bevacizumab in first-line advanced EGFRnon-small-cell lung cancer.

Translational lung cancer research·2023

Multi-Institutional Randomized Phase II Trial of Gefitinib for Previously Treated Patients With Advanced Non-Small-Cell Lung Cancer.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2023

See all related articles